Keynote address: Modulation of normal tissue toxicity by combined modality therapy: Considerations for improving the therapeutic gain
- 28 February 1991
- journal article
- review article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 20 (2) , 319-325
- https://doi.org/10.1016/0360-3016(91)90113-i
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Induced MyelosuppressionNew England Journal of Medicine, 1988
- Inhibition of the protective effect of cyclophosphamide by pre-treatment with buthionine sulfoximineInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Dose and time effects of cis-diamminedichloroplatinum(II) and radiation on mouse duodenal cryptsRadiotherapy and Oncology, 1985
- Lung damage in mice from cyclophosphamide and thoracic irradiation: The effect of timingInternational Journal of Radiation Oncology*Biology*Physics, 1983
- Bleomycin and radiation-induced lung damage in miceThe British Journal of Radiology, 1983
- Adriamycin-irradiation cutaneous complicationsInternational Journal of Radiation Oncology*Biology*Physics, 1977
- Adriamycin cardiotoxicityThe American Journal of Surgical Pathology, 1977
- Limited proliferation of stem cells surviving alkylating agentsNature, 1976
- Radiation-adriamycin interactions: Preliminary clinical observationsCancer, 1975
- Potentiation of X-Ray Effects by Actinomycin DRadiology, 1959